Mutation may be responsible for diabetes risk in Mexican population

A research team directed by Dr. Karol Estrada analyzed genetic sequencing of 8000 Mexicans and found a mutated gene related to diabetes in 30% of mestizos and in half the indigenous population.

The largest genetic study of type II diabetes made between Mexican population has identified a gene present in mestizos (mixed race) and indigenous people of the country that rises five times the likelihood of developing the disease, compared to other populations of the world. The study integrates researchers from the Broad Institute (Harvard University and Massachusetts Institute of Technology), the National Institute of Nutrition and the Institute of Biomedical Research of the UNAM.

The research results were reported in June 2014 in the Journal of the American Medical Association, which notes that the mutated gene called SLC16A11 occurs in 30 percent of the mestizo population and up to 50 percent of the Mexican indigenous.

In this study, the scientist Karol Estrada, who works for the Broad Institute in Boston, directed the genetic sequencing analysis using computational elements.

To locate the gene, the first part of the research of DNA samples of more than eight thousand Mexicans, half of whom live in Mexico City and one in Los Angeles, California were taken; in the second stage just over four thousand attended nationals, with a ratio of 75 percent in the capital and the remaining in the California city.

Read the full, original story: Researcher finds diabetes related mutation in Mexican population

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Picture1-5
Science Disinformation Gap: The transatlantic battle over social media and censorship
Screenshot-2026-04-23-at-11.00.36-AM
Regulators' dilemma: Thalidomide, Metformin, and the cost of getting drug approvals wrong
ChatGPT Image May 10, 2026, 08_16_59 PM 2
Overmedicalization? RFK Jr.’s antidepressant crackdown raises conflict questions over his fee stake in Wisner Baum, the tort firm built on suing drug makers
ChatGPT-Image-May-12-2026-08_39_41-PM
GLP podcast: Big Pharma, Big Ag, Big Food—health harming industries or life-saving innovators?
Picture1-1
Cooling the planet with balloons: Could a geoengineering gamble slow global warming?
Screenshot-2026-05-12-at-9.58.31-PM
'He seems fine': Marty Makary out as FDA commissioner
Picture1-14
When superbugs threaten vulnerable children: Can AI help solve antibiotic resistance?
Screenshot-2026-05-12-at-10.05.11-AM
Pro-vaccine “hero” vs. an anti-vax “villain”: ‘Bad Vaxx’ video stirs MAHA backlash
Screenshot-2026-05-11-104424
Hantavirus outbreak research: Trump administration shut down study last year on rodent-to-human transmission
Screenshot 2026-05-11 at 11.30
Despite politicized disinformation, Midwest AI data centers are fueling a solar energy boom
ChatGPT Image May 12, 2026, 10_19_00 AM 2
Viewpoint— 'Muscular governance': How authoritarianism is surging corporate-linked energy misinformation
Screenshot-2026-05-01-at-1.29.41-PM
Viewpoint: What happens when whole grains meet modern food manufacturing? Labels don’t tell the whole story.
S
As vaccine rejectionism spreads, measles may be taking a more dangerous turn
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.